Every Form 4 that American Vanguard Corp (AVD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AVD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AVD filings page.
AMERICAN VANGUARD CORP (AVD) director-affiliated entities reported a significant common stock sale. On 2026-08-18, investment funds and separately managed accounts advised by Cruiser Capital Advisors, LLC, an affiliate of director Keith M. Rosenbloom, sold 556,580 shares of common stock at $2.20 per share. After this transaction, entities associated with Cruiser Capital reported 15,201 shares held indirectly, while Rosenbloom reported 66,283 shares held directly. Rosenbloom may be deemed to share voting and dispositive power over the Cruiser-held shares but disclaims beneficial ownership except to the extent of his pecuniary interest. The filing states the reported sale relates to securities held only by the Cruiser funds and accounts and was undertaken for reasons unrelated to American Vanguard’s business, operations or prospects.
AMERICAN VANGUARD CORP (AVD) director Steven D. Macicek reported a purchase of company stock. On 2026-08-17, he bought 19,000 shares of AVD common stock in an open-market or private transaction at $2.09 per share, bringing his directly held stake to 99,711 shares.
American Vanguard chief executive Douglas Kaye acquired 6,527 shares of common stock at $2.36 per share through the company's employee stock purchase plan. The shares were purchased via payroll deductions over a six-month period ending June 30, 2026, at 85% of fair market value. After this transaction, he holds 306,778 shares directly.
ROSENBLOOM KEITH M reported acquisition or exercise transactions in this Form 4 filing.
AMERICAN VANGUARD CORP director Keith M. Rosenbloom received a grant of 31,872 deferred stock units (DSUs) on Common Stock as part of the company’s 2026 non‑management director compensation program.
After this award, he directly holds 66,283 shares-equivalent, with each DSU settling into one common share when his board service ends, upon a change of control, or upon his death. The DSUs are nontransferable and carry no voting or dividend rights during his service.
American Vanguard Corp officer David T. Johnson received a grant of options to buy 20,000 shares of common stock. The options have an exercise price of $2.51 per share and were awarded as an incentive stock option grant.
The options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary. Following this award, Johnson holds options for 20,000 underlying common shares directly.
AMERICAN VANGUARD CORP director and CEO Douglas Kaye received a grant of 50,000 stock options. These options allow the purchase of 50,000 shares of Common Stock at an exercise price of $2.51 per share. The award is compensation-related, not an open-market trade.
The incentive stock options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary. After this grant, Kaye holds 50,000 options directly, giving potential future equity exposure if the options vest and are exercised.
American Vanguard Corp’s chief executive officer, Douglas Kaye, bought additional company stock in the open market. On this transaction, the CEO purchased 5,000 shares of Common Stock at a price of $2.50 per share. After the purchase, his directly owned stake increased to 300,251 shares.
McDougal Rubin J reported acquisition or exercise transactions in this Form 4 filing.
AMERICAN VANGUARD CORP director Rubin J. McDougal received 31,872 deferred stock units (DSUs) as compensation. The award was granted in connection with the company’s 2026 annual stockholders’ meeting and is recorded at no cash cost per unit.
Each DSU represents the right to receive one share of common stock when the award settles. Settlement occurs at the earlier of the director leaving the board, a change of control, or the director’s death. Until then, the DSUs are nontransferable and carry no voting or dividend rights.
American Vanguard Corp’s Chief Commercial Officer, Michael Joseph DiPaola, received an incentive stock option grant. The award covers 20,000 options to buy common stock at an exercise price of $2.51 per share.
The options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary, June 4, 2036, if not exercised. This is a compensation-related equity grant rather than an open-market share purchase or sale.
AMERICAN VANGUARD CORP director Patrick E. Gottschalk received a grant of 31,872 deferred stock units. These DSUs were awarded as part of the compensation program for non-management directors in connection with the 2026 annual stockholders' meeting, at no cash cost per unit. Following the award, Gottschalk holds 223,577 shares or units of common stock-related interests directly. Each DSU converts into one share of common stock upon settlement, which occurs when his board service ends, upon a change of control, or upon his death.
American Vanguard Corp senior vice president Jared Straley received a grant of options to buy 20,000 shares of common stock. The incentive stock options have an exercise price of $2.51 per share, vest in full on the third anniversary of the June 4, 2026 grant, and expire on June 4, 2036.
American Vanguard Corp CHRO Shirin Khosravi received a grant of options to buy 20,000 shares of common stock. These incentive stock options have an exercise price of $2.51 per share and relate to 20,000 underlying common shares.
The options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary, June 4, 2036. Following this award, Khosravi holds options to acquire 20,000 shares directly, reflecting a compensation-related equity grant rather than an open-market purchase or sale.
AMERICAN VANGUARD CORP senior vice president of manufacturing Gilliam Nolteanous received a grant of stock options. The award covers 20,000 options to buy common stock at an exercise price of $2.51 per share.
These incentive stock options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary, June 4, 2036. Following this grant, Nolteanous holds 20,000 options directly, reflecting compensation rather than an open-market share purchase.
AMERICAN VANGUARD CORP officer Timothy J. Donnelly received a grant of options covering 20,000 shares of common stock. The options have an exercise price of $2.51 per share and were reported as a direct holding.
These incentive stock options vest in full on the third anniversary of the grant date and expire on the tenth anniversary of the grant date. The grant is categorized as a compensation-related acquisition, with no open-market buying or selling of common shares reported in this filing.
Macicek Steven D reported acquisition or exercise transactions in this Form 4 filing.
American Vanguard Corp director Steven D. Macicek reported an equity award of 31,872 deferred stock units (DSUs) of common stock. The units were granted at no cash cost as part of the company’s compensation program for non‑management directors in connection with the 2026 annual stockholders’ meeting.
Each DSU represents the right to receive one share of common stock upon settlement, which occurs when Macicek’s board service ends, upon a change of control, or upon his death. After this grant, he directly holds 80,711 shares or share-equivalent units. DSUs are nontransferable during service and carry neither voting nor dividend rights until they settle.
American Vanguard Corp director Mark R. Bassett received a grant of 31,872 deferred stock units (DSUs) of common stock as part of the company’s 2026 non-management director compensation program. Following this award, he directly holds 89,919 shares or DSUs in total. Each DSU converts into one common share upon settlement when his board service ends, upon a change of control, or upon his death, and carries no voting or dividend rights while outstanding.
Angelini Marisol reported acquisition or exercise transactions in this Form 4 filing.
American Vanguard Corp director Marisol Angelini received a stock grant. She was awarded 31,872 shares of Common Stock at no cash cost as part of the Company's compensation program for non-management directors in connection with the 2026 annual stockholders' meeting. Following this award, she directly holds 68,762 shares of American Vanguard common stock.
American Vanguard Corp director Patrick E. Gottschalk reported an open-market purchase of 25,000 shares of Common Stock at $2.70 per share. After this transaction, his directly held position increased to 191,705 shares, signaling a larger personal stake in the company.
AMERICAN VANGUARD CORP director Patrick E. Gottschalk bought 40,000 shares of Common Stock in the open market across two days. He purchased 20,000 shares on May 12 at $2.92 per share and 20,000 shares on May 13 at $2.95 per share. Following these transactions, he directly holds 166,705 shares of AMERICAN VANGUARD CORP common stock.
American Vanguard Corp. reported that Chief Executive Officer Douglas Kaye acquired additional company stock through its employee stock purchase plan. On 01/29/2026, he obtained 4,790 shares of common stock at $3.26 per share, funded via payroll deductions over the July 1, 2025 to December 31, 2025 period.
Following this transaction, Kaye beneficially owned 295,251 shares of American Vanguard common stock in total.
American Vanguard Corp. director reports share distribution from investment fund
A director of American Vanguard Corp. (AVD) reported receiving 47,281 shares of common stock on 11/26/2025. This was recorded on a Form 4 as an acquisition at a reported price of $0 per share, reflecting that it was not a market purchase.
After this transaction, the director beneficially owns 126,705 shares of American Vanguard common stock in direct ownership. According to the explanation, the shares came from a pro‑rata distribution by a private investment fund controlled by Cruiser Capital, in which the reporting person was a non‑managing member. The distribution occurred in connection with the fund’s dissolution and did not involve any purchase, sale, or payment of consideration by the director.
American Vanguard Corp director updates share holdings after fund distribution. A fund managed by Cruiser Capital, where the reporting person is Managing Member, distributed an aggregate of 231,404 American Vanguard common shares to its members on a pro rata basis for no consideration on 11/26/2025. As part of this, 217,503 shares previously attributed to the fund are no longer counted as shares in which Cruiser Capital has a beneficial or pecuniary interest.
Within that total distribution, Cruiser Capital received 13,901 shares, which continue to be included in the reporting person’s holdings. Following the transaction, the reporting person reports 34,411 American Vanguard shares held directly and 571,781 shares held indirectly through Cruiser Capital’s managed funds and separately managed accounts, over which he may be deemed to share voting and dispositive power.